Article info

Original research
IgG1 pan-neurofascin antibodies identify a severe yet treatable neuropathy with a high mortality

Authors

  1. Correspondence to Dr Simon Rinaldi, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, OX1 2JD, UK; simon.rinaldi{at}nhs.net
View Full Text

Citation

Fehmi J, Davies AJ, Walters J, et al
IgG1 pan-neurofascin antibodies identify a severe yet treatable neuropathy with a high mortality

Publication history

  • Received February 10, 2021
  • Accepted August 9, 2021
  • First published August 16, 2021.
Online issue publication 
September 15, 2021

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.